Mechanisms of Disease: vitamin D and inflammatory bowel disease (original) (raw)

• Holick MF (1994) McCollum Award Lecture, 1994: vitamin D—new horizons for the 21st century. Am J Clin Nutr 60: 619–630
  Article CAS Google Scholar
• Haussler MR et al. (1998) The nuclear vitamin D receptor: biological and molecular regulatory properties revealed. J Bone Miner Res 13: 325–349
  Article CAS Google Scholar
• Sutton AL and MacDonald PN (2003) Vitamin D: more than a “bone-a-fide” hormone. Mol Endocrinol 17: 777–791
  Article CAS Google Scholar
• Zittermann A (2003) Vitamin D in preventive medicine: are we ignoring the evidence? Br J Nutr 89: 552–572
  Article CAS Google Scholar
• Li YC et al. (2002) 1,25-Dihydroxyvitamin D(3) is a negative endocrine regulator of the renin-angiotensin system. J Clin Invest 110: 229–238
  Article CAS Google Scholar
• Endo I et al. (2003) Deletion of vitamin D receptor gene in mice results in abnormal skeletal muscle development with deregulated expression of myoregulatory transcription factors. Endocrinology 144: 5138–5144
  Article CAS Google Scholar
• Zinser G et al. (2002) Vitamin D(3) receptor ablation alters mammary gland morphogenesis. Development 129: 3067–3076
  CAS PubMed Google Scholar
• Nagpal S et al. Non-calcemic action of vitamin D receptor ligands. Endocrine Rev, in press
• Holick MF (2003) Vitamin D: A millenium perspective. J Cell Biochem 88: 296–307
  Article CAS Google Scholar
• Bhalla AK et al. (1983) Specific high-affinity receptors for 1,25-dihydroxyvitamin D3 in human peripheral blood mononuclear cells: presence in monocytes and induction in T lymphocytes following activation. J Clin Endocrinol Metab 57: 1308–1310
  Article CAS Google Scholar
• Provvedini DM et al. (1983) 1,25-dihydroxyvitamin D3 receptors in human leukocytes. Science 221: 1181–1183
  Article CAS Google Scholar
• Manolagas SC et al. (1986) The antiproliferative effect of calcitriol on human peripheral blood mononuclear cells. J Clin Endocrinol Metab 63: 394–400
  Article CAS Google Scholar
• Brennan A et al. (1987) Dendritic cells from human tissues express receptors for the immunoregulatory vitamin D3 metabolite, dihydroxycholecalciferol. Immunology 61: 457–461
  CAS PubMed PubMed Central Google Scholar
• Veldman CM et al. (2000) Expression of 1,25-dihydroxyvitamin D(3) receptor in the immune system. Arch Biochem Biophys 374: 334–338
  Article CAS Google Scholar
• Rigby WF et al. (1984) Inhibition of T lymphocyte mitogenesis by 1,25-dihydroxyvitamin D3 (calcitriol). J Clin Invest 74: 1451–1455
  Article CAS Google Scholar
• Bhalla AK et al. (1984) 1,25-Dihydroxyvitamin D3 inhibits antigen-induced T cell activation. J Immunol 133: 1748–1754
  CAS PubMed Google Scholar
• Stio M et al. (2001) Suppressive effect of 1,25-dihydroxyvitamin D3 and its analogues EB 1089 and KH 1060 on T lymphocyte proliferation in active ulcerative colitis. Biochem Pharmacol 61: 365–371
  Article CAS Google Scholar
• Stio M et al. (2002) Synergistic inhibitory effect of cyclosporin A and vitamin D derivatives on T-lymphocyte proliferation in active ulcerative colitis. Am J Gastroenterol 97: 679–689
  Article CAS Google Scholar
• Rigby WF et al. (1987) Regulation of lymphokine production and human T lymphocyte activation by 1,25-dihydroxyvitamin D3. Specific inhibition at the level of messenger RNA. J Clin Invest 79: 1659–1664
  Article CAS Google Scholar
• Lemire JM (1992) Immunomodulatory role of 1,25-dihydroxyvitamin D3. J Cell Biochem 49: 26–31
  Article CAS Google Scholar
• Alroy I et al. (1995) Transcriptional repression of the interleukin-2 gene by vitamin D3: direct inhibition of NFATp/AP-1 complex formation by a nuclear hormone receptor. Mol Cell Biol 15: 5789–5799
  Article CAS Google Scholar
• Cippitelli M and Santoni A (1998) Vitamin D3: a transcriptional modulator of the interferon-gamma gene. Eur J Immunol 28: 3017–3030
  Article CAS Google Scholar
• Boonstra A et al. (2001) 1alpha,25-Dihydroxyvitamin d3 has a direct effect on naive CD4(+) T cells to enhance the development of Th2 cells. J Immunol 167: 4974–4980
  Article CAS Google Scholar
• Mahon BD et al. (2003) The targets of vitamin D depend on the differentiation and activation status of CD4 positive T cells. J Cell Biochem 89: 922–932
  Article CAS Google Scholar
• Nashold FE et al. (2001) Rag-1-dependent cells are necessary for 1,25-dihydroxyvitamin D(3) prevention of experimental autoimmune encephalomyelitis. J Neuroimmunol 119: 16–29
  Article CAS Google Scholar
• Mattner F et al. (2000) Inhibition of Th1 development and treatment of chronic-relapsing experimental allergic encephalomyelitis by a non-hypercalcemic analogue of 1,25-dihydroxyvitamin D(3). Eur J Immunol 30: 498–508
  Article CAS Google Scholar
• D'Ambrosio D et al. (1998) Inhibition of IL-12 production by 1,25-dihydroxyvitamin D3. Involvement of NF-kappaB downregulation in transcriptional repression of the p40 gene. J Clin Invest 101: 252–262
  Article CAS Google Scholar
• Penna G and Adorini L (2000) 1 Alpha,25-dihydroxyvitamin D3 inhibits differentiation, maturation, activation, and survival of dendritic cells leading to impaired alloreactive T cell activation. J Immunol 164: 2405–2411
  Article CAS Google Scholar
• Piemonti L et al. (2000) Vitamin D3 affects differentiation, maturation, and function of human monocyte-derived dendritic cells. J Immunol 164: 4443–4551
  Article CAS Google Scholar
• Berer A et al. (2000) 1,25-Dihydroxyvitamin D(3) inhibits dendritic cell differentiation and maturation in vitro. Exp Hematol 28: 575–583
  Article CAS Google Scholar
• Canning MO et al. (2001) 1-alpha,25-Dihydroxyvitamin D3 (1,25(OH)(2)D(3)) hampers the maturation of fully active immature dendritic cells from monocytes. Eur J Endocrinol 145: 351–357
  Article CAS Google Scholar
• Gregori S et al. (2001) Regulatory T cells induced by 1 alpha,25-dihydroxyvitamin D3 and mycophenolate mofetil treatment mediate transplantation tolerance. J Immunol 167: 1945–1953
  Article CAS Google Scholar
• Barrat FJ et al. (2002) In vitro generation of interleukin 10-producing regulatory CD4(+) T cells is induced by immunosuppressive drugs and inhibited by T helper type 1 (Th1)- and Th2-inducing cytokines. J Exp Med 195: 603–616
  Article CAS Google Scholar
• Podolsky DK (2002) Inflammatory bowel disease. N Engl J Med 347: 417–429
  Article CAS Google Scholar
• Loftus EV Jr and Sandborn WJ (2002) Epidemiology of inflammatory bowel disease. Gastroenterol Clin North Am 31: 1–20
  Article Google Scholar
• Loftus EV Jr (2004) Clinical epidemiology of inflammatory bowel disease: Incidence, prevalence, and environmental influences. Gastroenterology 126: 1504–1517
  Article Google Scholar
• Sellu DP (1986) Seasonal variation in onset of exacerbations of ulcerative proctocolitis. J R Coll Surg Edinb 31: 158–160
  CAS PubMed Google Scholar
• Moum B et al. (1996) Seasonal variations in the onset of ulcerative colitis. Gut 38: 376–378
  Article CAS Google Scholar
• Zeng L and Anderson FH (1996) Seasonal change in the exacerbations of Crohn's disease. Scand J Gastroenterol 31: 79–82
  Article CAS Google Scholar
• Webb AR et al. (1988) Influence of season and latitude on the cutaneous synthesis of vitamin D3: exposure to winter sunlight in Boston and Edmonton will not promote vitamin D3 synthesis in human skin. J Clin Endocrinol Metab 67: 373–378
  Article CAS Google Scholar
• Vogelsang H et al. (1989) Bone disease in vitamin D-deficient patients with Crohn's disease. Dig Dis Sci 34: 1094–1099
  Article CAS Google Scholar
• Holick MF (2002) Vitamin D: the underappreciated D-lightful hormone that is important for skeletal and cellular health. Curr Opin Endocrinol Diabetes 9: 87–98
  Article CAS Google Scholar
• Probert CS et al. (1990) Inflammatory bowel disease in the rural Indian subcontinent: a survey of patients attending mission hospitals. Digestion 47: 42–46
  Article CAS Google Scholar
• Probert CS et al. (1992) Epidemiological study of ulcerative proctocolitis in Indian migrants and the indigenous population of Leicestershire. Gut 33: 687–693
  Article CAS Google Scholar
• Carr I and Mayberry JF (1999) The effects of migration on ulcerative colitis: a three-year prospective study among Europeans and first- and second-generation South Asians in Leicester (1991-1994). Am J Gastroenterol 94: 2918–2922
  CAS PubMed Google Scholar
• Driscoll RH Jr et al. (1982) Vitamin D deficiency and bone disease in patients with Crohn's disease. Gastroenterology 83: 1252–1258
  PubMed Google Scholar
• Harries AD et al. (1985) Vitamin D status in Crohn's disease: association with nutrition and disease activity. Gut 26: 1197–1203
  Article CAS Google Scholar
• Andreassen H et al. (1998) Regulators of calcium homeostasis and bone mineral density in patients with Crohn's disease. Scand J Gastroenterol 33: 1087–1093
  Article CAS Google Scholar
• Abitbol V et al. (1995) Metabolic bone assessment in patients with inflammatory bowel disease. Gastroenterology 108: 417–422
  Article CAS Google Scholar
• Bernstein CN et al. (1995) Decreased bone density in inflammatory bowel disease is related to corticosteroid use and not disease diagnosis. J Bone Miner Res 10: 250–256
  Article CAS Google Scholar
• Abreu MT et al. (2004) Measurement of vitamin D levels in inflammatory bowel disease patients reveals a subset of Crohn's disease patients with elevated 1,25-dihydroxyvitamin D and low bone mineral density. Gut 53: 1129–1136
  Article CAS Google Scholar
• Bernstein CN et al. (2003) AGA technical review on osteoporosis in gastrointestinal diseases. Gastroenterology 124: 795–841
  Article Google Scholar
• Schoon EJ et al. (2000) Bone mineral density in patients with recently diagnosed inflammatory bowel disease. Gastroenterology 119: 1203–1208
  Article CAS Google Scholar
• Lee SH et al. (2000) Decreased trabecular bone mineral density in newly diagnosed inflammatory bowel disease patients in Korea. J Gastroenterol Hepatol 15: 512–518
  Article CAS Google Scholar
• Lamb EJ et al. (2002) Metabolic bone disease is present at diagnosis in patients with inflammatory bowel disease. Aliment Pharmacol Ther 16: 1895–902
  Article CAS Google Scholar
• Malabanan A et al. (1998) Redefining vitamin D insufficiency. Lancet 351: 805–806
  Article CAS Google Scholar
• Chapuy MC et al. (1997) Prevalence of vitamin D insufficiency in an adult normal population. Osteoporos Int 7: 439–443
  Article CAS Google Scholar
• Kuhn R et al. (1991) Generation and analysis of interleukin-4 deficient mice. Science 254: 707–710
  Article CAS Google Scholar
• Kuhn R et al. (1993) Interleukin-10-deficient mice develop chronic enterocolitis. Cell 75: 263–274
  Article CAS Google Scholar
• MacDonald TT (1994) Gastrointestinal inflammation. Inflammatory bowel disease in knockout mice. Curr Biol 4: 261–263
  Article CAS Google Scholar
• Cantorna MT et al. (2000) 1,25-Dihydroxycholecalciferol prevents and ameliorates symptoms of experimental murine inflammatory bowel disease. J Nutr 130: 2648–2652
  Article CAS Google Scholar
• Aranda R et al. (1997) Analysis of intestinal lymphocytes in mouse colitis mediated by transfer of CD4+, CD45RBhigh T cells to SCID recipients. J Immunol 158: 3464–3473
  CAS PubMed Google Scholar
• Morrissey PJ et al. (1993) CD4+ T cells that express high levels of CD45RB induce wasting disease when transferred into congenic severe combined immunodeficient mice. Disease development is prevented by cotransfer of purified CD4+ T cells. J Exp Med 178: 237–244
  Article CAS Google Scholar
• Froicu M et al. (2003) A crucial role for the vitamin D receptor in experimental inflammatory bowel diseases. Mol Endocrinol 17: 2386–2392
  Article CAS Google Scholar